Duyuru • May 06
Umicore Announces Supervisory Board Appointments Umicore at its ordinary and extraordinary shareholders’ meeting held on April 30th 2026 approved the appointment of Anna Bertona and Benjamin Loh as new Supervisory Board members for a term of 3 years. Valuation Update With 7 Day Price Move • May 04
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €19.51, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in Germany. Total loss to shareholders of 29% over the past three years. Declared Dividend • May 04
Dividend of €0.35 announced Shareholders will receive a dividend of €0.35. Ex-date: 5th May 2026 Payment date: 7th May 2026 Dividend yield will be 2.0%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (31% earnings payout ratio) and cash flows (31% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. EPS is expected to grow by 8.8% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Duyuru • May 03
Umicore Sa Announces Chief Financial Officer Changes, Effective August 1, 2026 Umicore SA announced the appointment of Lily Liu as Chief Financial Officer effective August 1, 2026. Mrs. Liu succeeds current CFO Wannes Peferoen who will leave the Company after twenty years of dedicated service. Post handover on August 1st, Mr. Peferoen will serve in a special advisory capacity until February 28, 2027 to ensure a seamless transition. Mrs. Liu joins Umicore from Synthomer, a specialty chemicals company listed on the London Stock Exchange, where she serves as CFO since July 2022. Holding both British and Australian citizenship, she brings more than twenty years of financial leadership experience across the chemicals, manufacturing, and engineering industries. Before her time at Synthomer, Mrs. Liu was CFO at Essentra plc, and previously held CFO positions with Xaar plc and Smiths Detection. She is also a non-executive director and audit committee member at DCC plc. Reported Earnings • Mar 31
Full year 2025 earnings released: EPS: €1.60 (vs €6.15 loss in FY 2024) Full year 2025 results: EPS: €1.60 (up from €6.15 loss in FY 2024). Revenue: €19.4b (up 30% from FY 2024). Net income: €384.5m (up €1.86b from FY 2024). Profit margin: 2.0% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue is expected to decline by 41% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 3.2%. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Duyuru • Mar 30
Umicore SA, Annual General Meeting, Apr 30, 2026 Umicore SA, Annual General Meeting, Apr 30, 2026, at 17:00 Romance Standard Time. Reported Earnings • Feb 21
Full year 2025 earnings released: EPS: €1.60 (vs €6.15 loss in FY 2024) Full year 2025 results: EPS: €1.60 (up from €6.15 loss in FY 2024). Revenue: €19.4b (up 30% from FY 2024). Net income: €384.5m (up €1.86b from FY 2024). Profit margin: 2.0% (up from net loss in FY 2024). The move to profitability was driven by higher revenue. Revenue is expected to decline by 56% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.4%. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Buy Or Sell Opportunity • Dec 17
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 33% to €17.49. The fair value is estimated to be €14.02, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to decline by 37% per annum. Earnings are forecast to grow by 22% per annum over the same time period. Valuation Update With 7 Day Price Move • Nov 21
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €14.44, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 55% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €15.09 per share. Buy Or Sell Opportunity • Sep 25
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 12% to €14.42. The fair value is estimated to be €12.00, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to decline by 41% per annum. Earnings are forecast to grow by 21% per annum over the same time period. Duyuru • Aug 22
Umicore SA to Report Fiscal Year 2025 Results on Feb 20, 2026 Umicore SA announced that they will report fiscal year 2025 results on Feb 20, 2026 Reported Earnings • Aug 04
First half 2025 earnings released: EPS: €0.57 (vs €6.12 loss in 1H 2024) First half 2025 results: EPS: €0.57 (up from €6.12 loss in 1H 2024). Revenue: €8.69b (up 17% from 1H 2024). Net income: €136.7m (up €1.61b from 1H 2024). Profit margin: 1.6% (up from net loss in 1H 2024). Revenue is expected to decline by 42% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 3.4%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance. New Risk • Aug 03
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 16% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Minor Risks Dividend is not well covered by cash flows (213% cash payout ratio). Large one-off items impacting financial results. New Risk • Jun 24
New major risk - Revenue and earnings growth Earnings have declined by 44% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 44% per year over the past 5 years. Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.8% average weekly change). Upcoming Dividend • Apr 21
Upcoming dividend of €0.17 per share Eligible shareholders must have bought the stock before 28 April 2025. Payment date: 30 April 2025. The company is not currently making a profit but it is cash flow positive. Trailing yield: 6.5%. Within top quartile of German dividend payers (4.4%). Higher than average of industry peers (4.1%). New Risk • Apr 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.1% average weekly change). Reported Earnings • Mar 23
Full year 2024 earnings released: €6.15 loss per share (vs €1.60 profit in FY 2023) Full year 2024 results: €6.15 loss per share (down from €1.60 profit in FY 2023). Revenue: €14.9b (down 19% from FY 2023). Net loss: €1.48b (down 484% from profit in FY 2023). Revenue is expected to decline by 40% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 3.9%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance. Duyuru • Mar 21
Umicore Announces Supervisory Board Changes Umicore at its ordinary and special shareholders’ meetings to be held on April 24, 2025 announced after serving 10 years on Umicore’s Supervisory Board, Mr. Mark Garrett announced that he will not seek to renew his mandate at the upcoming 2025 ordinary shareholders’ meeting. Mr. Laurent Raets, Groupe Bruxelles Lambert (GBL), also announced his intention to step down from the Supervisory Board, after having served 6 years on the Board. Declared Dividend • Feb 24
Final dividend of €0.17 announced Shareholders will receive a dividend of €0.17. Ex-date: 28th April 2025 Payment date: 30th April 2025 Dividend yield will be 3.8%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is well covered by cash flows (42% cash payout ratio). The dividend has remained flat since 10 years ago. However, payments have been volatile during that time. Duyuru • Feb 17
Umicore SA, Annual General Meeting, Apr 30, 2025 Umicore SA, Annual General Meeting, Apr 30, 2025. Reported Earnings • Feb 15
Full year 2024 earnings released: €6.15 loss per share (vs €1.60 profit in FY 2023) Full year 2024 results: €6.15 loss per share (down from €1.60 profit in FY 2023). Revenue: €14.9b (down 19% from FY 2023). Net loss: €1.48b (down 484% from profit in FY 2023). Revenue is expected to decline by 38% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 3.9%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. Duyuru • Feb 15
Umicore Sa Proposes Annual Dividend, Payable on April 30, 2025 Umicore SA's Supervisory Board will propose a gross annual dividend of €0.50 per share for 2024 at the Annual General Meeting on 24 April 2025. This is a reduction from the €0.80 per share paid for 2023. Considering the interim dividend of €0.25 per share paid in August 2024, a gross amount of €0.25 per share will be paid on 30 April 2025, subject to shareholder approval. Based on the closing share price on 31 December 2024 of €9.96, the dividend yield amounts to approximately 5%. Duyuru • Feb 14
Umicore SA to Report Fiscal Year 2024 Final Results on Mar 21, 2025 Umicore SA announced that they will report fiscal year 2024 final results on Mar 21, 2025 Duyuru • Feb 01
Umicore SA to Report First Half, 2025 Results on Aug 01, 2025 Umicore SA announced that they will report first half, 2025 results on Aug 01, 2025 Duyuru • Sep 23
Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD) Umicore SA(ENXTBR:UMI) dropped from FTSE All-World Index (USD) Upcoming Dividend • Aug 12
Upcoming dividend of €0.17 per share Eligible shareholders must have bought the stock before 19 August 2024. Payment date: 21 August 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 7.0%. Within top quartile of German dividend payers (4.9%). Higher than average of industry peers (5.6%). Declared Dividend • Jul 31
First half dividend of €0.17 announced Shareholders will receive a dividend of €0.17. Ex-date: 19th August 2024 Payment date: 21st August 2024 Dividend yield will be 4.4%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months. However, the dividend is covered by cash flows (57% cash payout ratio). The dividend has increased by an average of 4.8% per year over the past 10 years. However, payments have been volatile during that time. Reported Earnings • Jul 28
First half 2024 earnings released: €6.12 loss per share (vs €0.93 profit in 1H 2023) First half 2024 results: €6.12 loss per share (down from €0.93 profit in 1H 2023). Revenue: €7.52b (down 25% from 1H 2023). Net loss: €1.47b (down €1.70b from profit in 1H 2023). Revenue is expected to decline by 43% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 4.4%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 28 percentage points per year, which is a significant difference in performance. New Risk • Jul 28
New minor risk - Financial position The company has a high level of debt. Net debt to equity ratio: 70% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (70% net debt to equity). Paying a dividend despite being loss-making. Buy Or Sell Opportunity • Jul 28
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 37% to €13.13. The fair value is estimated to be €16.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Meanwhile, the company became loss making. Duyuru • Jul 26
Umicore SA to Report Fiscal Year 2024 Results on Feb 14, 2025 Umicore SA announced that they will report fiscal year 2024 results on Feb 14, 2025 New Risk • Jun 13
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 4.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 4.6% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (122% cash payout ratio). Buy Or Sell Opportunity • Jun 10
Now 21% overvalued Over the last 90 days, the stock has fallen 20% to €16.82. The fair value is estimated to be €13.92, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to decline by 40% per annum. Earnings are forecast to grow by 0.6% per annum over the same time period. Duyuru • Feb 16
Umicore SA to Report First Half, 2024 Results on Jul 26, 2024 Umicore SA announced that they will report first half, 2024 results on Jul 26, 2024